Throughout the pandemic, testing has continued to be one of the biggest issues, particularly in the United States. Some scientists say that the solution is to rethink our COVID-19 testing strategy, focusing on making faster, cheaper tests. While these more cost-effective tests may be lower in sensitivity than the PCR tests and perhaps not as accurate, they would allow for more people to get tested and receive faster results. The system can also help improve case tracking—which is essential as more people return to work, school, and daily lives. Eric Topol, the founder and director of the Scripps Research Translational Institute, talks about how these tests can look ahead for infectious patients rather than those already infected. Plus, epidemiologist Anne Wyllie walks us through what the process would look like to develop a rapid test.
- AI-facilitated health care requires education of clinicians April 2, 2021
- Roberto Burioni on Conquering COVID and Charming the Skeptics April 2, 2021
- COVID Writing Goes Viral: How Literary and Social Media Writing Became a Lifeline During the Pandemic March 26, 2021
- Eric Topol on the Pandemic Year: The Hyper-Acceleration of the Life Sciences March 19, 2021